• DOI:10.1016/j.vaccine.2016.01.028
Corpus ID: 25617048

Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.

@article{Rappazzo2016RecombinantMO,
  title={Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.},
  author={C. Rappazzo and H. Watkins and C. Guarino and Annie Chau and J. Lopez and M. DeLisa and C. Leifer and G. Whittaker and D. Putnam},
  journal={Vaccine},
  year={2016},
  volume={34 10},
  pages={
          1252-8
        }
}

C. Rappazzo, H. Watkins, +6 authors D. Putnam

Published 2016

Biology, Medicine

Vaccine

Currently approved influenza vaccines predominantly protect through antibodies directed against the highly variable glycoprotein hemagglutinin (HA), necessitating annual redesign and formulation based on epidemiological prediction of predominant circulating strains. More conserved influenza protein sequences, such as the ectodomain of the influenza M2 protein, or M2e, show promise as a component of a universal influenza A vaccine, but require a Th1-biased immune response for activity. Recently… CONTINUE READING

View on PubMed

manuscript.elsevier.com

Save to Library

Create Alert

Cite

Launch Research Feed